1. Fujiwara, S., Zhao, X., Teoh, C., Jafe, D. H. & Taguchi, Y. Disease burden of fractures among patients with osteoporosis in Japan: health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs. J. Bone Miner. Metab. 37, 307–318 (2019).
2. Remily, E. A. et al. Hip fracture trends in America between 2009 and 2016. Geriatr. Orthop. Surg. Rehabil. 11, 1–10 (2020).
3. Holick, M. F. Te infuence of vitamin D on bone health across the life cycle. J. Nutr. 135, 2726S-2727S (2005).
4. Terabe, Y. et al. Vitamin D defciency in elderly women in nursing homes: Investigation with consideration of decreased activation function from the kidneys. J. Am. Geriatr. Soc. 60, 251–255 (2012).
5. Caccamo, D., Ricca, S., Currò, M. & Ientile, R. Health risks of hypovitaminosis D: A review of new molecular insights. Int. J. Mol. Sci. 19, 892 (2018).
6. Forrest, K. Y. Z. & Stuhldreher, W. L. Prevalence and correlates of vitamin D defciency in US adults. Nutr. Res. 31, 48–54 (2011).
7. Wei, Q. S. et al. Relation of age, sex and bone mineral density to serum 25-hydroxyvitamin D levels in Chinese women and men. Orthop. Surg. 7, 343–349 (2015).
8. O’Sullivan, M., Nic Suibhne, T., Cox, G., Healy, M. & O’Morain, C. High prevalence of vitamin D insufciency in healthy Irish adults. Ir. J. Med. Sci. 177, 131–134 (2008).
9. Richy, F. et al. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: A comparative meta-analysis. Calcif. Tissue Int. 76, 176–186 (2005).
10. O’Donnell, S., Moher, D., Tomas, K., Hanley, D. A. & Cranney, A. Systematic review of the benefts and harms of calcitriol and alfacalcidol for fractures and falls. J. Bone Miner. Metab. 26, 531–542 (2008).
11. Papadimitropoulos, E. et al. VIII: Meta-analysis of the efcacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr. Rev. 23, 560–569 2002).
12. Morita, D. et al. Short-range ultraviolet irradiation with LED device efectively increases serum levels of 25(OH)D. J. Photochem. Photobiol. B Biol. 164, 256–263 (2016).
13. Morita, D. et al. Efects of ultraviolet irradiation with a LED device on bone metabolism associated with vitamin D defciency in senescence-accelerated mouse P6. Heliyon 6, e03499 (2020).
14. Makida, K. et al. Low energy irradiation of narrow-range UV-LED prevents osteosarcopenia associated with vitamin D defciency in senescence-accelerated mouse prone 6. Sci. Rep. 10, 1–15 (2020).
15. Wang, H. et al. Identifcation of circRNA-associated ceRNA network in BMSCs of OVX models for postmenopausal osteoporosis. Sci. Rep. 10, 1–11 (2020).
16. Shao, M. Construction of an miRNA-regulated pathway network reveals candidate biomarkers for postmenopausal osteoporosis. Comput. Math. Methods Med. 2017, (2017).
17. McCarthy, M. S., Elshaw, E. B., Szekely, B. M. & Beltran, T. Novel phototherapy kiosk shows promise as a treatment option for low vitamin D. Mil. Med. 186, 722–728 (2021).
18. Webb, A. R., Decosta, B. R. & Holick, M. F. Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J. Clin. Endocrinol. Metab. 68, 882–887 (1989).
19. Van Dijk, A. Quantum yield for the photo-degradation of Vitamin D3. Photochem. Photobiol. Sci. 16, 690–693 (2017).
20. Lindsay, R. et al. Consensus development statement: who are candidates for prevention and treatment for osteoporosis. Osteoporos. Int. 7, 1–6 (1997).
21. Ji, M. & Yu, Q. Primary osteoporosis in postmenopausal women. Chronic Dis. Transl. Med. 1, 9–13 (2015).
22. Pérez-López, F. R., Chedraui, P. & Pilz, S. Vitamin D supplementation afer the menopause. Terap. Adv. Endocrinol. Metab. 11, 1–13 (2020).
23. Tella, S. H. & Gallagher, J. C. Prevention and treatment of postmenopausal osteoporosis. J. Steroid Biochem. Mol. Biol. 142, 155–170 (2014).
24. Pacifci, R. Estrogen defciency, T cells and bone loss. Cell. Immunol. 252, 68–80 (2008).
25. Girgis, C. M. et al. Vitamin D receptor ablation and vitamin D defciency result in reduced grip strength, altered muscle fbers, and increased myostatin in mice. Calcif. Tissue Int. 97, 602–610 (2015).
26. Girgis, C. M. et al. Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function. J. Cachexia. Sarcopenia Muscle 10, 1228–1240 (2019).
27. Komori, T. Animal models for osteoporosis. Eur. J. Pharmacol. 759, 287–294 (2015).
28. Mao, L. et al. Infuence of diabetic state and vitamin D defciency on bone repair in female mice. Bone 61, 102–108 (2014).
29. Wong, K. C. et al. (-)-Epiafzelechin protects against ovariectomy-induced bone loss in adult mice and modulate osteoblastic and osteoclastic functions in vitro. Nutrients 9, 1–14 (2017).
30. Ding, L. C. et al. Rcan2 and estradiol independently regulate body weight in female mice. Oncotarget 8, 48098–48109 (2017).
31. Malley, R. C., Muller, H. K., Norval, M. & Woods, G. M. Dietary vitamin D alters the response of the skin to UVB-irradiation depending on the genetic background of the mice. Photochem. Photobiol. Sci. 12, 536–545 (2013).
32. Coe, L. M., Tekalur, S. A., Shu, Y., Baumann, M. J. & Mccabe, L. R. Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation. J. Cell. Physiol. 230, 1944–1953 (2015).
33. Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2–17 (2013).
34. McGlade, J. P. et al. Efect of both ultraviolet B irradiation and histamine receptor function on allergic responses to an inhaled antigen. J. Immunol. 178, 2794–2802 (2007).
35. Satué, M., Córdoba, A., Ramis, J. M. & Monjo, M. UV-irradiated 7-dehydrocholesterol coating on polystyrene surfaces is converted to active vitamin D by osteoblastic MC3T3-E1 cells. Photochem. Photobiol. Sci. 12, 1025–1035 (2013).
36. Ham, J. R. et al. Methoxsalen supplementation attenuates bone loss and infammatory response in ovariectomized mice. Chem. Biol. Interact. 278, 135–140 (2017).